Abstract

Objective: Investigations have not yet been carried out to identify the different morphological forms of amastigotes present in patients with cutaneous leishmaniasis (CL) in Sri Lanka. Thus, this paper describes the existence of different amastigote forms in cutaneous lesions for the first time in Sri Lanka. Methods: This was a retrospective study. One hundred and thirty skin smears were investigated to identify the different morphometric forms of L. donovani. In addition, demographic data (age, gender, occupation, household characteristics, and geographic area) were analyzed using department records. Results: Of the 130 samples, 84 (60.83%) samples had amastigote forms. Three (2.31%) samples had amastigotes in intracellular locations while 43 (33.08%) had amastigotes extracellularly. Nineteen (14.62%) samples had amastigotes in intracellular and extracellular locations simultaneously. Promastigote-like structures (PLS) were found in 65 (50%) samples. Of the 65 samples, 19 (14.62%) had both PLS and amastigote forms. PLS alone (no association with amastigote forms) were found in 46 (35.38%) samples. Amastigotes were found predominantly in lesions Conclusion: Microscopic examinations of skin smears revealed the presence of promastigote-like structures for the first time in patients with CL in Sri Lanka. Therefore, we suggest that different morphometric features of amastigotes should not be ignored as they may be useful in diagnosis of CL in clinically suspected patients.

Highlights

  • Leishmaniasis is a vector-borne parasitic disease caused by an obligate intracellular protozoan of the genus Leishmania

  • The highest incidence of cutaneous leishmaniasis (CL) was reported from patients who were involved in outdoor activities (47.69%) followed by the unemployed group (44%)

  • In the present study as well, we have identified the amastigotes in both locations (Figures 1 and 2) in CL patients in Sri Lanka

Read more

Summary

Introduction

Leishmaniasis is a vector-borne parasitic disease caused by an obligate intracellular protozoan of the genus Leishmania. This disease is endemic in 66 Old World and 22 New World countries in the tropics, subtropics and southern Europe.[1,2,3,4] According to World Health Organization (WHO) estimates, 1.5 million cutaneous leishmaniasis cases and 500,000 visceral leishmaniasis cases occur annually and 12 million people were infected globally.[5] leishmaniasis is considered as an emerging and re-emerging infectious disease due to its wider geographical distribution with a high incidence.[5] Leishmaniasis is capable of causing a spectrum of clinical syndromes ranging from cutaneous ulcerations to systemic infections - cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL) and visceral leishmaniasis (VL) or “kala-azar”. Fourth (diffused cutaneous leishmaniasis (DCL) and fifth forms (post-kala-azar dermal syndrome (PKDS) have been described.[6,7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call